Evidence map›Paper›PMID 34764099›Full record

ArticleBMJ case reports2021

Progressive myocardial dysfunction following COVID-19.

Miroslawa Maria Gorecka, Sharmaine Thirunavukarasu, Eylem Levelt, John P Greenwood

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Miroslawa Maria GoreckaLeeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.ORCID 0000-0002-5688-8980
Sharmaine ThirunavukarasuLeeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Eylem LeveltLeeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
John P GreenwoodLeeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK J.Greenwood@leeds.ac.uk.ORCID 0000-0002-2861-0914
University of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CardiomyopathiesCOVID-19HumansSARS-CoV-2Ventricular Function, Leftcardiovascular magnetic resonanceCOVID-19heart failure

Identifiers

PMID34764099
PMCPMC8587344
OpenAlexW3213833412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.